Patent ID: 8592156

Claim:
A method of assessing a patient with diffuse large B-cell lymphoma (DLBCL), comprising: (a) obtaining a sample of the patient's tumor; and (b) determining in the sample the level of expression of a gene combination consisting of U2AF1, RNF2, ZC3H7B, CCNI, PSMD11, ABLIM1, GYG2, CAMK2G, NF1, SEQ ID NO: 1, TRIM66, FBXO21, MKNK2, FYTTD1, GET4, CABLES2, FMNL3, C22orf27, TBCEL, ZNF707, SEQ ID NO: 2, CSTB, BAHCC1, LOC723809, NPIP, gene coding for cDNA FLJ40566 fis clone THYMU2004733, LOC730367, RXFP2, MGC24125, SEQ ID NO: 3, PTP4A1, OSBP, HNRNPD, AHCYL1, BMP2K, IDS, SERPINB9, CSRP2BP, CD58, HERC4, MAGOH, TMBIM4, SFRS12, FAS, ZNF333, SEQ ID NO: 4, USP6, CHD6, LOC653160, SEQ ID NO: 5, SRPR, MIR21, ARHGAP18, SEQ ID NO:6, CBFA2T2, TIMP3, CTBS, USP16, RASA1 and YJEFN3.